Unilever share price slips on Alicorp deal: what ULVR investors are watching next
29 January 2026

Unilever share price slips on Alicorp deal: what ULVR investors are watching next

London, January 29, 2026, 08:32 (GMT) — Regular session

  • Unilever shares edged down about 0.5% in early London trading
  • Company agreed to sell its Home Care business in Colombia and Ecuador to Alicorp, the Peruvian company
  • Investors are shifting focus to Unilever’s mid-February earnings, eager to spot any fresh moves in the company’s portfolio

Unilever’s shares dipped in early London trading Thursday after the company sold its home care business in Colombia and Ecuador to Peruvian rival Alicorp. By 08:32 GMT, the stock was down 0.45% at 4,793.75 pence.

Investors want steady, reliable growth from major consumer staples companies—not just price increases and cost cuts. Unilever has talked more about “sharpening” its portfolio, and this deal represents another small step in that direction.

With no price disclosed, the market is left guessing the deal’s value. Attention now shifts to what other assets could be on the block and whether selling them genuinely boosts execution or just slices through the company’s layers.

Unilever revealed the sale covers local household and laundry brands like Fab, 3D, Aromatel, and Deja. The transaction still needs regulatory approval and must meet standard closing conditions. “It aligns with our ambition to sharpen our portfolio and focus on the categories where we can lead, innovate and grow sustainably,” said Reginaldo Ecclissato, President of Unilever Markets. Unilever

Alicorp called the transaction an asset purchase. According to a filing with Peru’s securities regulator (SMV), its subsidiaries in Colombia and Ecuador have inked agreements to buy 100% of Unilever’s home care business assets in those countries. The deal awaits regulatory approval in both markets. No financial terms or timelines were disclosed.

Unilever’s team in Ecuador insisted business will proceed normally. Marcos Dueñas, general manager of Unilever Ecuador, said the decision followed a portfolio review. “Alicorp knows the category well,” he told the local news outlet Primicias. The transition won’t affect operations. Primicias

An adviser on the transaction shared a similar perspective. Inverlink, acting as Unilever’s financial adviser for the sale, described the move as consistent with Unilever’s strategy to concentrate on its core “power brands.” They also noted the deal is expected to accelerate Alicorp’s expansion throughout the Andean region. El Universo

Home care, which includes detergents, cleaners, and laundry products, continues to be a fiercely contested sector. Unilever is up against heavyweight rivals such as Procter & Gamble and Reckitt, plus strong local contenders. Smaller, country-specific portfolios may generate profits, but they tend to sap management focus and marketing budgets.

The deal awaits regulatory approval, with authorities able to prolong the review or attach conditions in critical areas. Since terms remain undisclosed, investors are left guessing the proceeds and whether this sale signals a simple exit or part of a larger strategic reshuffle.

Unilever’s Q4 and full-year 2025 results are due Feb. 12, marking the next key date. Investors will watch closely for news on disposals, reinvestment strategies, and the 2026 demand outlook. The company is also lined up to speak at the CAGNY Conference on Feb. 17.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY

Pfizer

NYSE: PFE 93 / 100
#2 TACTICAL BUY

AMD

NASDAQ: AMD 91 / 100
#3 STRONG BUY

AerCap

NYSE: AER 90 / 100
#4 BUY ONLY ON PULLBACK

Booking Holdings

NASDAQ: BKNG 88 / 100
#5 BUY ON WEAKNESS

Visa

NYSE: V 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.
3i Group share price jumps 14% as Action update sparks fresh bets — what’s next
Previous Story

3i Group share price jumps 14% as Action update sparks fresh bets — what’s next

Haleon share price drops again as HLN stock extends slide ahead of Feb results
Next Story

Haleon share price drops again as HLN stock extends slide ahead of Feb results